$0.10 Earnings Per Share Expected for Ceridian HCM Holding Inc (NYSE:CDAY) This Quarter

Share on StockTwits

Equities analysts forecast that Ceridian HCM Holding Inc (NYSE:CDAY) will post $0.10 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Ceridian HCM’s earnings. The lowest EPS estimate is $0.08 and the highest is $0.12. Ceridian HCM reported earnings of $0.05 per share in the same quarter last year, which suggests a positive year over year growth rate of 100%. The company is expected to issue its next quarterly earnings results on Monday, November 4th.

On average, analysts expect that Ceridian HCM will report full-year earnings of $0.50 per share for the current year, with EPS estimates ranging from $0.47 to $0.54. For the next fiscal year, analysts expect that the business will report earnings of $0.69 per share, with EPS estimates ranging from $0.62 to $0.81. Zacks’ EPS calculations are a mean average based on a survey of research firms that follow Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.05. The firm had revenue of $196.30 million during the quarter, compared to analysts’ expectations of $192.29 million. Ceridian HCM had a net margin of 4.19% and a return on equity of 2.34%. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.44) earnings per share.

CDAY has been the subject of a number of recent research reports. Barclays set a $50.00 price target on shares of Ceridian HCM and gave the stock a “hold” rating in a research note on Wednesday, July 31st. Jefferies Financial Group upgraded shares of Ceridian HCM from a “hold” rating to a “buy” rating and lifted their price target for the stock from $58.00 to $65.00 in a research note on Monday, August 19th. Mizuho began coverage on shares of Ceridian HCM in a research note on Wednesday. They issued a “buy” rating and a $65.00 price target for the company. Credit Suisse Group boosted their price objective on shares of Ceridian HCM from $45.00 to $52.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 31st. Finally, Zacks Investment Research upgraded shares of Ceridian HCM from a “strong sell” rating to a “hold” rating in a research report on Thursday, June 6th. Seven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $55.33.

In other Ceridian HCM news, EVP Lisa M. Sterling sold 6,250 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $49.30, for a total value of $308,125.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Ozzie J. Goldschmied sold 63,000 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $53.99, for a total transaction of $3,401,370.00. The disclosure for this sale can be found here. Insiders have sold a total of 10,201,162 shares of company stock valued at $503,176,581 in the last 90 days. Insiders own 26.90% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Treasurer of the State of North Carolina lifted its holdings in Ceridian HCM by 34.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 25,998 shares of the company’s stock valued at $1,305,000 after purchasing an additional 6,680 shares in the last quarter. Nomura Holdings Inc. acquired a new stake in Ceridian HCM in the second quarter valued at approximately $10,243,000. Verition Fund Management LLC acquired a new stake in Ceridian HCM in the second quarter valued at approximately $207,000. United Services Automobile Association grew its position in Ceridian HCM by 30.2% in the second quarter. United Services Automobile Association now owns 10,243 shares of the company’s stock valued at $514,000 after acquiring an additional 2,374 shares in the last quarter. Finally, Bamco Inc. NY grew its position in Ceridian HCM by 8.2% in the second quarter. Bamco Inc. NY now owns 2,562,171 shares of the company’s stock valued at $128,621,000 after acquiring an additional 195,002 shares in the last quarter. 77.32% of the stock is currently owned by institutional investors.

Shares of CDAY stock traded down $1.00 during trading on Friday, reaching $57.06. The company’s stock had a trading volume of 1,006,792 shares, compared to its average volume of 1,146,702. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market capitalization of $8.25 billion, a price-to-earnings ratio of -1,141.20 and a beta of 1.59. The stock’s 50-day moving average price is $51.54 and its 200 day moving average price is $50.21. Ceridian HCM has a 1-year low of $31.39 and a 1-year high of $58.95.

Ceridian HCM Company Profile

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Read More: Coverage Ratio

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nucor  Releases Q3 2019 Earnings Guidance
Nucor Releases Q3 2019 Earnings Guidance
Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell


 
© 2006-2019 Zolmax.